Global Cell and Gene Therapy Market Size & Trends Report Segmented by Therapy Type (Cell, Gene), Indication (Oncology, Autoimmune Diseases, Others), End-user (Hospitals, Specialty Centers, Others) Industry Analysis & Regional Forecasts to 2030

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2025-2026)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Cell and Gene Therapy Marke"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Rising prevalence of genetic disorders and cancers
          • Expanding applications of CAR-T and stem cell therapies
          • Increasing approvals from regulatory agencies
          • Advancements in gene editing technologies
          • Personalized medicine and precision therapies gaining traction
        • Restraints
          • High cost of treatment and complex manufacturing processes
          • Challenges in long-term safety and efficacy assessments
          • Regulatory and ethical concerns surrounding gene modifications
        • Opportunities
          • Expansion of allogeneic (off-the-shelf) cell therapies
          • Integration of AI in gene therapy research and drug development
          • Rising demand for regenerative medicine applications
          • Growing investments from biotech firms and pharmaceutical giants
        • Key Market Trends
          • Development of next--viral gene delivery systems
          • Increasing focus on combination therapies
          • Adoption of decentralized manufacturing models for cell therapy
        • Unmet Market Needs
        • Industry Speaks
        • Pipeline Analysis
    • "5">
    • Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By Therapy Type, USD Million
      • Introduction
      • Cell Therapy
      • Gene Therapy
    • Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By Indication, USD Million
      • Introduction
      • Oncology
      • Autoimmune Diseases
      • Neurological Diseases
      • Cardiovascular Diseases
      • Others
    • Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By End-user, USD Million
      • Introduction
      • Hospitals & Speciality Clinics
      • Pharma & Biotech Companies
      • Academic Research Institutes
      • Others
    • Global Cell and Gene Therapy Market Size & Forecast (2023-2030), Btrong>
      • Introduction
      • North America Cell and Gene Therapy Market Size & Forecast (2023-2030), By Country, USD Million
        • US
          • Market Size & Forecast, By Therapy Type (USD Million)
          • Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Canada
          • Market Size & Forecast, By Therapy Type (USD Million)
          • Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
      • Europe Cell and Gene Therapy Market Size & Forecast (2023-2030), By Country, USD Million
        • UK
          • Market Size & Forecast, By Therapy Type (USD Million)
          • Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (li>Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • France
          • Market Size & Forecast, By Therapy Type (USD Million)
          • Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Italy
          • Market Size & Forecast, By Therapy Type (USD Million)
          • Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Spain
          • Market Size & Forecast, By Therapy Type (USD Million)
          • Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Rest of Europe
          • Market Size & Foreca-user (USD Million)
      • Asia Pacific (APAC) Cell and Gene Therapy Market Size & Forecast (2023-2030), By Country, USD Million
        • China
          • Market Size & Forecast, By Therapy Type (USD Million)
          • Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Japan
          • Market Size & Forecast, By Therapy Type (USD Million)
          • Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • India
          • Market Size & Forecast, By Therapy Type (USD Million)
          • Market Size & Forecast, By Indication (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Rest of Asia Pacific
    • Latin America (LATAM) Cell and Gene Therapy Market Size & Forecast (2023-2030), USD Million
      • Market Size & Forecast, By Therapy Type (USD Million)
      • Market Size & Forecast, By Indication (USD Million)
      • Market Size & Forecast, By End-user (USD Million)
    • Middle East & Africa (MEA) Cell and Gene Therapy Market Size & Forecast (2023-2030), USD Million
      • Market Size & Forecast, By Therapy Type (USD Million)
      • Market Size & Forecast, By Indication (USD Million)
      • Market Size &a"9">
      • Competitive Landscape
        • Key Players and their Competitive Positioning
          • Key Player Comparison
          • Segment-wise Player Mapping
          • Market Share Analysis (2024)
          • Company Categorization Matrix
            • Dominants/Leaders
            • New Entrants
            • Emerging Players
            • Innovative Players
          • Key Strategies Assessment, By Player (2022-2025)
            • New Product Launch/Approval
            • Partnerships, Agreements, & Collaborations
            • Mergers & Acquisitions
            • Geographic Expansion
  1. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

  • Sartorius AG; Novartis AG
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Charles River Laboratories
  • Cell and Gene Therapy Catapult
  • Lonza
  • WuXi AppTec
  • Takara Bio Inc.
  • Bristol Myers Squibb
  • FUJIFILM Holdings Corporation
  • Other Prominent Players

Note: *Indicative list

**For listed companies